L'Oreal Paris DOUBLE Laser Renew Triple Action Anti-Ageing Day Cream,

Transform your skincare routine with the Revitalift Laser Triple Action Anti-Ageing Day Cream, featuring a powerful NEW formula designed to deliver visible anti-ageing results. This advanced day cream is expertly formulated with three top dermatologist-validated actives: Pro-Retinol, which helps to smooth wrinkles and renew skin texture; Hyaluronic Acid, renowned for its ability to intensely hydrate and re-plump the skin; and Vitamin C* (Vitamin Cg), which boosts skin radiance and visibly corrects uneven skin tone. Targeting major signs of ageing, this potent formula smooths wrinkles, firms the skin, and brightens the overall look of your complexion. Validated by dermatologists, it is effective on all skin types, with clinically proven results showing skin feels more toned and firmer, replumped with moisture, and exhibits a more even texture, along with a reduction in the look of fine lines and crow's feet. Achieve a renewed and youthful appearance with this essential anti-ageing moisturizer. Ingredients: AQUA / WATER • GLYCERIN • ISOHEXADECANE • HYDROXYPROPYL TETRAHYDROPYRANTRIOL • DIMETHICONE • ALUMINUM STARCH OCTENYLSUCCINATE • ISOPROPYL ISOSTEARATE • PROPYLENE GLYCOL • NYLON-12 • OCTYLDODECANOL • CETYL ALCOHOL • BEHENYL ALCOHOL • AMMONIUM POLYACRYLOYLDIMETHYL TAURATE • ACETYL DIPEPTIDE-1 CETYL ESTER • ADENOSINE • CAPRYLOYL SALICYLIC ACID • PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE • SODIUM HYALURONATE • TRIETHANOLAMINE • TRISODIUM ETHYLENEDIAMINE DISUCCINATE • ASCORBYL GLUCOSIDE • RETINYL PALMITATE • BUTYLENE GLYCOL • CETEARYL ALCOHOL • CETEARYL GLUCOSIDE • C13-14 ISOPARAFFIN • DISODIUM STEAROYL GLUTAMATE • HYDROXYETHYLCELLULOSE • LAURETH-7 • MYRISTIC ACID • PALMITIC ACID • PEG-100 STEARATE • POLYACRYLAMIDE • POLYETHYLENE • SORBITAN LAURATE • STEARIC ACID • TOCOPHEROL • BENZYL ALCOHOL • CITRONELLOL • ISOEUGENOL • LIMONENE • LINALOOL • CI 15985 / YELLOW 6 • CI 19140 / YELLOW 5 • PHENOXYETHANOL • PARFUM / FRAGRANCE. (F.I.L. Z299156/1).